Skip to main content

Steris Corp(STE-N)
NYSE

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time

Profile

STERIS plc, develops, manufactures and markets infection prevention, decontamination, microbial reduction, and surgical and gastrointestinal support products and services. On Nov 2, 2015, STERIS completed the acquisition of Synergy Health plc following which it was re-registered under the name ' STERIS plc. Currently, STERIS serves healthcare, pharmaceutical, research, industrial and governmental customers across the globe. The majority of STERIS' revenues is derived from the healthcare and pharmaceutical industries. STERIS provides its products and services in more than 60 countries. The company's key areas of strategic focus include developing its customer base in Europe, the Middle East and the Asia Pacific region.

Key Executives

NameTitle
Daniel A. CarestioCEO/Director/President

More from The Globe

Short sales on the TSX: What bearish investors are betting against
Larry MacDonald